Cadwalader allows sharing content.
Email to a friend or colleague:
From
To
Subject
Email Cadwalader advised longtime client AngioDynamics in the sale of its Dialysis product portfolio and BioSentry Tract Sealant System Biopsy product to Merit Medical Systems, Inc. for $100 million in cash. AngioDynamics intends to use net proceeds from the sale to eliminate its existing debt and support further strategic investments in growth and profitability. https://www.cadwalader.com/news/news-release/cadwalader-advises-angiodynamics-in-its-100-million-sale-of-certain-assets-to-merit-medical-systems